KMT2A and acute lymphoblastic leukemia: 11q23/MLL translocations are seen in around 22% of patients with ALL which is much more frequent as compared to AML with only 5% of patients being affected.70 In patients with ALL, t(4;11) is most frequent, followed by t(11;19).